SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001578563-23-000006
Filing Date
2023-02-13
Accepted
2023-02-13 16:40:19
Documents
1
Period of Report
2022-06-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 6119
  Complete submission text file 0001578563-23-000006.txt   9357
Mailing Address BAYERWERK, GEBAEUDE W11 KAISER-WILHELM-ALLEE LEVERKUSEN 2M D-51368
Business Address BAYERWERK, GEBAEUDE W11 KAISER-WILHELM-ALLEE LEVERKUSEN 2M D-51368 492143081933
BAYER AKTIENGESELLSCHAFT (Reporting) CIK: 0001144145 (see all company filings)

Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40440 | Film No.: 23619197
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 511 BENEDICT AVE. TARRYTOWN NY 10591-5097
BAYER HEALTHCARE LLC (Reporting) CIK: 0001231517 (see all company filings)

State of Incorp.: DE
Type: 3 | Act: 34 | File No.: 001-40440 | Film No.: 23619200

Mailing Address ENERGIEWEG 1 MIJDRECHT P7 3641
Business Address ENERGIEWEG 1 MIJDRECHT P7 3641 00 31 297 280 666
Bayer World Investments B.V. (Reporting) CIK: 0001820027 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40440 | Film No.: 23619198

Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 382-3281
Senti Biosciences, Inc. (Issuer) CIK: 0001854270 (see all company filings)

IRS No.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 100 BAYER BOULEVARD WHIPPANY NJ 07981
Business Address 100 BAYER BOULEVARD WHIPPANY NJ 07981 (862) 404-3000
Bayer US Holding LP (Reporting) CIK: 0001965754 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40440 | Film No.: 23619199